Diagnosis and differential diagnosis 
Gonococcal culture
Prevention 
Dr Erica Stewart, Centenary Institute[/caption]
Chelsea Felkai, MPS[/caption]
Working with the nursing staff to understand when PRN (as required) chemical restraint might be used, and ensuring other options have been exhausted first, has shown the most reduction in how much psychotropic medications have been used so far. The numbers are relatively small, but to be honest, this is largely because the facility had great protocols to begin with.
Dr Natalie Soulsby FPS[/caption]
Associate Professor Luke Grzeskowiak[/caption]
PSA NSW Excellence Award winners announced
Four exemplary pharmacists were celebrated for their leadership, community impact, and commitment to health innovation.
What you missed at PSA22 – Day 2
PSA22 continued on Saturday with a wide-ranging line-up of award presentations, therapeutic updates and industry engagement opportunities.
Hot topics at the 2019 FIP Congress
Medicine access, technological disruption to traditional care models, ethical dilemmas and gender equity dominated the program for the 79th International Pharmacy Federation (FIP) Congress.
The...
Supporting terminally ill patients
Having an easily-accessible palliative care pharmacist in every community would improve medicine management for terminally ill Australians, said Helen Stone MPS, PSA State and Territory Manager South Australia and Northern Territory.
The role of the pharmacist in motor neurone disease
Motor neurone disease (MND) is a group of progressive, degenerative disorders of the motor neurones. Multidisciplinary care of patients is required as the disease progresses.
Loneliness
Despite being the most technologically connected society in history, we appear to be the loneliest. Robust scientific evidence has declared loneliness a significant danger to the health of the individual and the public health system.
